Treatment Refractory MAC Lung Disease
2 clinical trials · Condition
◉ Watch Treatment Refractory MAC Lung Disease
| Record | Firm | Date |
|---|---|---|
| ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension (NCT06418711) | Mannkind Corporation | 2024-09-11 |
| Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease (NCT05327803) | AN2 Therapeutics, Inc | 2022-05-20 |
Track Treatment Refractory MAC Lung Disease automatically
Every clearance here is in the API, with alerts when new ones post.